{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:07:48Z","timestamp":1790755668447,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.jaut.2013.01.003","type":"journal-article","created":{"date-parts":[[2013,2,11]],"date-time":"2013-02-11T19:16:34Z","timestamp":1360610194000},"page":"94-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Complement C2 siRNA mediated therapy of myasthenia gravis in mice"],"prefix":"10.1016","volume":"42","author":[{"given":"Ruksana","family":"Huda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"T\u00fcz\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premkumar","family":"Christadoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2013.01.003_bib1","first-page":"159","article-title":"Myasthenia gravis","volume":"88","author":"Vincent","year":"2002","journal-title":"Adv Neurol"},{"key":"10.1016\/j.jaut.2013.01.003_bib2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJM197805182982004","article-title":"Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation","volume":"298","author":"Drachman","year":"1978","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.01.003_bib3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00005072-198003000-00005","article-title":"Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis","volume":"39","author":"Sahashi","year":"1980","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.jaut.2013.01.003_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1084\/jem.147.4.973","article-title":"Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis","volume":"147","author":"Lennon","year":"1978","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2013.01.003_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.expneurol.2004.06.005","article-title":"Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis","volume":"189","author":"Kaminski","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jaut.2013.01.003_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/clim.1999.4807","article-title":"Animal models of myasthenia gravis","volume":"94","author":"Christadoss","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2013.01.003_bib7","series-title":"Myasthenia gravis: mechanisms of disease and immune intervention","article-title":"Targeting classical complement pathway and IL-6 in experimental autoimmune myasthenia gravis","author":"Tuzun","year":"2010"},{"key":"10.1016\/j.jaut.2013.01.003_bib8","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.4049\/jimmunol.171.7.3847","article-title":"Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis","volume":"171","author":"T\u00fcz\u00fcn","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.01.003_bib9","first-page":"265","article-title":"Targeting classical complement pathway to treat complement mediated autoimmune diseases","volume":"632","author":"T\u00fcz\u00fcn","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaut.2013.01.003_bib10","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1212\/WNL.39.10.1359","article-title":"Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis","volume":"39","author":"Tsujihata","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.01.003_bib11","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.4049\/jimmunol.140.8.2589","article-title":"C5 gene influences the development of murine myasthenia gravis","volume":"140","author":"Christadoss","year":"1988","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.01.003_bib12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1212\/WNL.43.6.1167","article-title":"Myasthenia gravis: quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30 patients","volume":"43","author":"Nakano","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.01.003_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jneuroim.2006.10.014","article-title":"Pros and cons of treating murine myasthenia gravis with anti-C1q antibody","volume":"182","author":"T\u00fcz\u00fcn","year":"2007","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2013.01.003_bib14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2353\/ajpath.2008.080103","article-title":"Gene silencing of complement C5a receptor using siRNA for preventing ischemia\/reperfusion injury","volume":"173","author":"Zheng","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaut.2013.01.003_bib15","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/j.1600-6143.2006.01427.x","article-title":"Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene","volume":"6","author":"Zheng","year":"2006","journal-title":"Am J Transplant"},{"issue":"Suppl 24","key":"10.1016\/j.jaut.2013.01.003_bib16","first-page":"22","article-title":"Complement in host defense","author":"Schultz","year":"1980","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1016\/j.jaut.2013.01.003_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1971.tb01433.x","article-title":"Isolation of the principal neurotoxin of two Naja naja subspecies","volume":"21","author":"Karlsson","year":"1971","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jaut.2013.01.003_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1523s95","article-title":"Experimental autoimmune myasthenia gravis in the mouse","author":"Wu","year":"2011","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.jaut.2013.01.003_bib19","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.175.3.2018","article-title":"IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1","volume":"175","author":"Yang","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.01.003_bib20","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4049\/jimmunol.138.3.856","article-title":"Constitutive and IL 1-regulated murine complement gene expression is strain and tissue specific","volume":"138","author":"Falus","year":"1987","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.01.003_bib21","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","article-title":"Quantitative expression of toll-like receptor 1 -10 mRNA and sensitivity to CpG oligodeoxynucleotides in cellular subsets of human peripheral blood mononuclear cells","volume":"168","author":"Hornung","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.01.003_bib22","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1248\/bpb.28.886","article-title":"Tissue-specific mRNA expression profiles of human toll-like receptors and related genes","volume":"28","author":"Nishimura","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jaut.2013.01.003_bib23","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1087262","article-title":"Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway","volume":"301","author":"Yamamoto","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jaut.2013.01.003_bib24","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1016\/j.molimm.2007.02.007","article-title":"Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflamatory cytokines","volume":"44","author":"Uehara","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaut.2013.01.003_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2567.2012.03559.x","article-title":"Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects)","volume":"136","author":"Weber","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2013.01.003_bib26","series-title":"The complement system: novel roles in health and disease","first-page":"201","author":"Szebeni","year":"2004"},{"key":"10.1016\/j.jaut.2013.01.003_bib27","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1084\/jem.165.6.1494","article-title":"Covalent association of C3b with C4b within C5 convertase of the classical complement pathway","volume":"165","author":"Takata","year":"1987","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2013.01.003_bib28","doi-asserted-by":"crossref","first-page":"38476","DOI":"10.1074\/jbc.M307017200","article-title":"Formation of high affinity C5 convertase of the classical pathway of complement","volume":"278","author":"Rawal","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaut.2013.01.003_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaut.2011.05.006","article-title":"Complement and cytokine based therapeutic strategies in myasthenia gravis","volume":"37","author":"T\u00fcz\u00fcn","year":"2011","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.01.003_bib30","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.4049\/jimmunol.170.8.4310","article-title":"A\u00a0peptide derived from the parasite receptor, complement C2 receptor inhibitor trispanning, suppresses immune complex-mediated inflammation in mice","volume":"170","author":"Inal","year":"2003","journal-title":"J\u00a0Immunol"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:07:14Z","timestamp":1760256434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841113000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":30,"alternative-id":["S0896841113000048"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2013.01.003","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement C2 siRNA mediated therapy of myasthenia gravis in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2013.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}